Standout Papers

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer 2019 2026 2021 2023 575
  1. Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer (2019)
    Aditya Bardia, Ingrid A. Mayer et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 8 from Science/Nature 58 standout
Sub-graph 1 of 24

Citing Papers

Polymeric Nanoparticles for Drug Delivery
2024 Standout
Deciphering breast cancer: from biology to the clinic
2023 Standout
2 intermediate papers

Works of Robert Iannone being referenced

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
2019 Standout
Abstract S1-09: A phase Ib study of pembrolizumab (MK-3475) in patients with advanced triple-negative breast cancer
2015

Author Peers

Author Last Decade Papers Cites
Robert Iannone 946 664 570 42 2.1k
Andrew L. Gilman 730 637 802 60 2.7k
Richard Ghalie 626 402 351 68 1.6k
Carl Lenarsky 319 867 438 53 1.9k
W. Lange 803 587 228 59 1.9k
Chad May 665 533 415 34 2.6k
P L Duffey 1073 276 674 30 2.7k
Lewis Cohen 506 323 434 41 1.9k
W. Hiddemann 623 748 247 98 2.0k
Athina Giannoudis 910 520 621 49 2.6k
Nick J. Gonchoroff 559 378 464 41 2.4k

All Works

Loading papers...

Rankless by CCL
2026